Jazz Pharmaceuticals PLC (JAZZ)

145.94
0.11 0.08
NASDAQ : Health Care
Prev Close 146.05
Open 146.52
Day Low/High 145.72 / 146.83
52 Wk Low/High 108.50 / 194.73
Volume 160.80K
Avg Volume 627.70K
Exchange NASDAQ
Shares Outstanding 59.74M
Market Cap 8.72B
EPS 6.60
P/E Ratio 22.76
Div & Yield N.A. (N.A)

Latest News

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.

How Investors Can Play the Trump Card: Cramer's 'Mad Money' Recap (Monday 1/23/17)

How Investors Can Play the Trump Card: Cramer's 'Mad Money' Recap (Monday 1/23/17)

Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.

Fitbit Is Out, Xilinx Is In: 'Mad Money' Lightning Round

Fitbit Is Out, Xilinx Is In: 'Mad Money' Lightning Round

Jim Cramer says the future doesn't look healthy for Fitbit, but he's bullish on Xilinx and T-Mobile.

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.

The Best Biopharma CEOs of 2016 Are...

The Best Biopharma CEOs of 2016 Are...

The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CSWC, FNV, INTT, SCHL, VSAT Downgrades: AE, ASH, CNTY, CVV, HCOM, JAZZ, JLL, KND, MAC, MGNX, NS, OLED, OLP, SCSC, SEAS, TGH, XNCR Initiations: ABTX Read on to get TheStreet Quant Ratings' detailed report:

Jazz Pharmaceuticals Stock Retreats as Q3 Falls Short

Jazz Pharmaceuticals Stock Retreats as Q3 Falls Short

Jazz Pharmaceuticals's third-quarter results missed analysts' projections.

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

But we could see more volatility in the market.

Pharma Has History of Price Gouging, Mylan Should Be No Surprise

Pharma Has History of Price Gouging, Mylan Should Be No Surprise

While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.

Jazz Pharmaceuticals (JAZZ) Stock Tumbles on Q2 Miss, Guidance

Jazz Pharmaceuticals (JAZZ) Stock Tumbles on Q2 Miss, Guidance

Jazz Pharmaceuticals (JAZZ) reported lower earnings and revenue for the 2016 second quarter and gave an outlook below Wall Street's expectations.

CMS Grants New Technology Add-On Payment To Defitelio For The Treatment Of Hepatic Veno-Occlusive Disease With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

CMS Grants New Technology Add-On Payment To Defitelio For The Treatment Of Hepatic Veno-Occlusive Disease With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

Add-On Payment to Provide Additional Medicare Reimbursement for Defitelio and to Support Patient Access in the Inpatient PPS Hospital Setting

3 Health Care Stocks Pushing The Sector Higher

3 Health Care Stocks Pushing The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.